{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T05:26:42Z","timestamp":1773379602683,"version":"3.50.1"},"reference-count":16,"publisher":"BMJ","issue":"11","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2023,10,30]]},"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:p>We report a case of a man with spinocerebellar ataxia (SCA) on high-dose amantadine who was admitted for acute on chronic dysphagia secondary to progression of SCA. Four days after oral medications were held due to patient\u2019s dysphagia, he developed fever, tachycardia and mild rigidity in extremities and became obtunded. Despite antibiotics treatment, the vitals and mental status changes persisted for 8\u2009days. When amantadine was resumed, the patient\u2019s vital signs and encephalopathy improved within 2\u2009days. This is among the first reports of amantadine withdrawal syndrome (AWS) in a patient without Parkinson\u2019s disease. Our case reinforces the importance of careful medication review at admission and consideration of pharmacologic side effects with not only medication initiation but also discontinuation.<\/jats:p>","DOI":"10.1136\/bcr-2023-256840","type":"journal-article","created":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T12:06:49Z","timestamp":1699963609000},"page":"e256840","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Amantadine withdrawal in a patient with spinocerebellar ataxia"],"prefix":"10.1136","volume":"16","author":[{"given":"Andrew","family":"Pak","sequence":"first","affiliation":[{"name":"Internal Medicine, Harbor-UCLA Medical Center, Torrance, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emiley","family":"Chang","sequence":"additional","affiliation":[{"name":"Internal Medicine, Harbor-UCLA Medical Center, Torrance, California, USA"},{"name":"The Lundquist Institute, Torrance, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,11,14]]},"reference":[{"key":"2025082723015536000_16.11.e256840.1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/105.1.1"},{"key":"2025082723015536000_16.11.e256840.2","doi-asserted-by":"publisher","DOI":"10.1080\/14734220510007914"},{"key":"2025082723015536000_16.11.e256840.3","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.40.9.1369"},{"key":"2025082723015536000_16.11.e256840.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-9877(98)90032-9"},{"key":"2025082723015536000_16.11.e256840.5","doi-asserted-by":"publisher","DOI":"10.1007\/BF03161096"},{"key":"2025082723015536000_16.11.e256840.6","doi-asserted-by":"crossref","unstructured":"Miller RG , Mitchell JD , Lyon M , et al . Riluzole for Amyotrophic lateral sclerosis (ALS)\/Motor neuron disease (MND). Cochrane Database Syst Rev 2007:CD001447. doi:10.1002\/14651858.CD001447.pub2","DOI":"10.1002\/14651858.CD001447.pub2"},{"key":"2025082723015536000_16.11.e256840.7","doi-asserted-by":"crossref","DOI":"10.1093\/omcr\/omaa133","article-title":"Amantadine withdrawal syndrome masquerading as COVID-19 encephalopathy: a case report and review of the literature","volume":"2021","author":"Murray","year":"2021","journal-title":"Oxf Med Case Reports"},{"key":"2025082723015536000_16.11.e256840.8","doi-asserted-by":"crossref","DOI":"10.1177\/003693308703200503","article-title":"Long term Amantadine treatment. The danger of withdrawal","volume":"32","author":"Wilson","year":"1987","journal-title":"Scott Med J"},{"key":"2025082723015536000_16.11.e256840.9","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1212\/WNL.50.5.1456","article-title":"Acute delirium after withdrawal of Amantadine in Parkinson\u2019s disease","volume":"50","author":"Factor","year":"1998","journal-title":"Neurology"},{"key":"2025082723015536000_16.11.e256840.10","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1212\/WNL.52.8.1717-d","article-title":"Acute delirium after withdrawal of Amantadine in Parkinson\u2019s disease","volume":"52","author":"Miyasaki","year":"1999","journal-title":"Neurology"},{"key":"2025082723015536000_16.11.e256840.11","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000460814","article-title":"A case report of severe delirium after Amantadine withdrawal","volume":"9","author":"Marxreiter","year":"2017","journal-title":"Case Rep Neurol"},{"key":"2025082723015536000_16.11.e256840.12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/PRA.0000000000000237","article-title":"The role of Amantadine withdrawal in 3 cases of treatment-refractory altered mental status","volume":"23","author":"Fryml","year":"2017","journal-title":"J Psychiatr Pract"},{"key":"2025082723015536000_16.11.e256840.13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/NRL.0000000000000330","article-title":"Parkinsonism-Hyperpyrexia syndrome after Amantadine withdrawal: case report and review of the literature","volume":"26","author":"Dos Santos","year":"2021","journal-title":"Neurologist"},{"key":"2025082723015536000_16.11.e256840.14","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30152-8"},{"key":"2025082723015536000_16.11.e256840.15","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3928\/0048-5713-20000501-14","article-title":"Central dopamine Hypoactivity and the pathogenesis of neuroleptic malignant syndrome","volume":"30","author":"Mann","year":"2000","journal-title":"Psychiatric Annals"},{"key":"2025082723015536000_16.11.e256840.16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14802\/jmd.12001","article-title":"Preliminary study of intravenous Amantadine treatment for ataxia management in patients with probable multiple system atrophy with predominant cerebellar ataxia","volume":"5","author":"Youn","year":"2012","journal-title":"J Mov Disord"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2023-256840","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T06:02:06Z","timestamp":1756360926000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2023-256840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":16,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,11,14]]},"published-print":{"date-parts":[[2023,11]]}},"alternative-id":["10.1136\/bcr-2023-256840"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2023-256840","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11]]}}}